Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04291079
What this trial is testing

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

Who this might be right for
Cancer
Scholar Rock, Inc. 112
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Testing effectiveness (Phase 2)Study completedNCT02401815
What this trial is testing

CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors

Who this might be right for
Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc. 51
Early research (Phase 1)Study completedNCT02699515
What this trial is testing

MSB0011359C (M7824) in Participants With Metastatic or Locally Advanced Solid Tumors

Who this might be right for
Solid Tumors
Merck KGaA, Darmstadt, Germany 114
Early research (Phase 1)Study completedNCT01648764
What this trial is testing

LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

Who this might be right for
Malignant Solid TumorSolid TumorMetastatic Tumor
Eli Lilly and Company 73
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Early research (Phase 1)Looking for participantsNCT05194982
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor

Who this might be right for
Locally Advanced or Metastatic Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 570
Early research (Phase 1)Study completedNCT02944396
What this trial is testing

Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
AbbVie 25
Early research (Phase 1)Study completedNCT00121680
What this trial is testing

A Phase I/Ib, Multicenter, Open-Label, Dose Escalation Study of E7080 in Patients With Solid Tumors and in Combination With Temozolomide in Patients With Advanced and/or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Eisai Inc. 115
Testing effectiveness (Phase 2)Study completedNCT04521179
What this trial is testing

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

Who this might be right for
HER2-positive Solid Tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 102
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Not Yet RecruitingNCT07778862
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors

Who this might be right for
Gynecological TumorsSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Early research (Phase 1)Looking for participantsNCT07086768
What this trial is testing

Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorMetastatic Solid Tumor
Lei Zheng 57
Early research (Phase 1)Looking for participantsNCT07071090
What this trial is testing

DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor Malignancies
Heronova Pharmaceuticals 32
Early research (Phase 1)Active Not RecruitingNCT06548217
What this trial is testing

A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Ono Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04995523
What this trial is testing

AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

Who this might be right for
Non-Small-Cell Lung Carcinoma
AstraZeneca 212
Testing effectiveness (Phase 2)Looking for participantsNCT06578624
What this trial is testing

Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Lamassu Bio Inc 70
Early research (Phase 1)Study completedNCT00927589
What this trial is testing

Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable Cancer

Who this might be right for
Solid Cancers
Genentech, Inc. 59
Early research (Phase 1)Looking for participantsNCT05262491
What this trial is testing

BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor

Who this might be right for
Gastrointestinal Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 96
Next Page